[London, 31 August 2023] – With Augnito voice-driven AI transcription capabilities now integrated into the OpenRad Cloud (by Biotronics3D), its English speaking users will benefit from the increased efficiency and functionality that Augnito’s native speech reporting offers.
Scribetech today announced the successful integration of Augnito Voice Services™, an AI-powered voice-driven speech recognition API/SDK, into OpenRad Cloud (by Biotronics3D) – a remote radiology reporting platform.
OpenRad is a supplier of innovative radiology solutions for static and mobile diagnostic imaging centres worldwide, empowering healthcare professionals and the wider clinical research community with fully digitalised workflow processes that connect people, technology, and data.
Augnito is a secure and portable clinical speech recognition suite that offers medical professionals highly accurate, fast, effortless ways to dictate and transcribe live clinical data, on any mobile or desktop device – without the need for typing or outsourced services. For integrators and systems developers, Augnito delivers effective speech-enablement and voice-driven capability to many applications and clinical systems.
With the Augnito Voice Services API/SDK integrated into the cloud-based reporting platform, OpenRad can assist a severely understaffed and overworked profession with time-saving, highly accurate speech recognition technology. The combined solution means radiologists can accommodate increasing workloads and ever-expanding levels of diagnostic reporting from wherever they have an internet connection.
By speech-enabling the OpenRad Cloud reporting solution, Augnito delivers enhanced value, increased efficiency, and clinical data accuracy to OpenRad’s thousands of reporters. As well as making workloads more manageable, this also positively impacts the patient journey – from diagnosis to hospital stays – with an improved more seamless continuum of care.
OpenRad has also selected to add Augnito Spectra as a standalone “off the shelf” speech recognition product to its solution offering. The two Augnito products address multiple technology challenges previously experienced by OpenRad reporters. Many of these issues were the result of legacy non-interoperable products that are effective in isolation, but do not work so well together as one cohesive workflow.
Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito stated: “Augnito is a disruptive innovation technology that carries Scribetech’s commitment to data accuracy along with our strong 20+ year heritage of delivering digital dictation solutions and transcription services to the NHS. It brings speech recognition to the clinical healthcare professionals who need it the most, alleviating clinical risk, cutting costs, and avoiding difficult and time-consuming upgrades on legacy systems.”
“In the UK, we look to provide Augnito speech recognition through a highly selective network of best in breed partners that share our approach to developing solutions that embrace AI innovation to enhance healthcare intelligence. OpenRad solidifies this strategy.”
“Augnito will augment the existing support and reporting benefits that our cloud-based reporting platform offers radiologists in the public and private healthcare system across the UK and English-speaking countries. This integration enables OpenRad to expand on its mission to transform healthcare through an open diagnostic network. At OpenRad we put patient outcomes first by speeding up clinical decision-making through the seamless connection and collaboration of healthcare experts, imaging providers, referrers, and their patients.” stated Brian Plackis Cheng, CEO of OpenRad.
For media enquiries, please contact [email protected]
Notes to editors
About Scribetech (UK) Ltd and Augnito
Scribetech (UK) Ltd is a clinical solutions innovator and official distributor of Augnito products in the UK and Ireland. The company co-developed Augnito with its sister company Augnito India Private Ltd fusing 20 years of highly accurate and secure transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own Deep Neural Network speech recognition engine with advanced voice AI technology. Augnito provides a secure, cloud-based, voice-driven AI clinical speech recognition product suite, offering fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings cost effective, seamless speech recognition to daily workflows and third-party clinical systems, quickly turning medical information into documentation that makes healthcare intelligence compliant and accessible where it is needed. Visit www.scribetech.co.uk for more details.
Founded in 2021 and based in London and Berlin, OpenRad delivers innovative radiology solutions for static and mobile diagnostic imaging centres worldwide. OpenRad aims to empower healthcare professionals and the wider research community by connecting people, technology, and data.
By combining the intelligent products and services of previously acquired Biotronics3D and Visbion, OpenRad can fully digitalise the workflow processes within the radiological diagnostic sphere. Its zero footprint SaaS based solutions speed up implementation, increase centre utilisation, provide remote access, and reduce cost of ownership. Visit www.openrad.com for further information.
In healthcare, new technology always seems to be promising a faster, smarter, better way of working. Solutions claim they’ll save you time and remove your stress, all while improving outcomes for patients and making their journeys more seamless. But those promises all need to be balanced against a simple, more pragmatic reality: budgets are always limited in the healthcare ‘business’.
Recently, the business of healthcare has been in the spotlight. With rising costs and widespread strikes for NHS workers with more on the horizon, there’s more pressure than ever to spend money effectively. Crucially, this doesn’t mean ceasing all spending. It means targeting your budget where the impact – on healthcare professionals, patients, and outcomes – will be biggest and where the value will be most effective.
With the NHS in crisis, now is the time for change: from overworked professionals burdened by manual reporting to a more agile, flexible way of working. And that transformation doesn’t have to mean huge investment, changes to your IT infrastructure, or expensive training.
The demands on healthcare have intensified
Waiting lists are increasing, hospital bed capacities are shrinking and, according to data from the British Medical Association, the average GP is responsible for 17% more patients on average compared to 2015. Accelerated by the pandemic, the healthcare needs of the UK have dramatically shifted in the past few years. It’s only natural, then, that the way healthcare professionals work needs to shift too.
However, healthcare in general is reluctant to invest in new technology. In a recent study by BT, 49% of NHS staff said the standard of technology at work was a source of stress. But while 29% strongly agree that innovation is hamstrung by a lack of funding, 37% identified cultural resistance to change as a significant barrier.
With this in mind, understanding the true value of new technology is key. The only way to overcome cultural resistance is with an objective approach – one that pits costs and price against value, reconciling the expense of a given technology with the impact on staff and patients.
Measuring the price and cost of AI-enhanced speech recognition
The healthcare industry has generally been willing to invest in AI, but Deloitte identifies the need to measure return on investment as key to continued transformation. AI-enhanced speech/voice recognition (instant digital transcription) gives users a faster, more flexible way to report and capture notes, including direct dictation into existing clinical workflows and applications. This has the potential to deliver a measurable return by saving a considerable amount of time and empowering staff to work efficiently – without compromising accuracy.
Augnito Spectra, our clinical speech recognition software, costs £576 (including VAT) per user, per year. With an average of 260 working days, that’s just £2.22 per day. Given that Augnito Spectra saves on average one hour a day – an hour that brings with it an implied cost – that’s a considerable return on investment. At the same time, Augnito has a positive impact on overworked users, improving not only performance and effectiveness but engagement, and retention. Compared to the costs of missed days due to stress or, worse, having to find someone new when people reach their limit and leave healthcare, Augnito is a significant saving.
For a few pounds per day, Trusts can empower their clinical professionals to work at their best. And that ultimately enables better healthcare outcomes for clinicians and medical staff and for patients – the most valuable output of all.
A speech recognition solution designed to create value
£2.22 per user, per day. That’s less than a pack of Nurofen (and other brands) to fend off the headache of slow, time-consuming reporting. It’s even less than a box of plasters to patch over the workload problem until people leave the healthcare sector.
Augnito Spectra also goes further to create value for your clinical staff and organisation. Designed to go wherever your people do, it includes:
• Mobile speech recognition on iOS or Android devices
• Seamless cloud-based notes, available on any device
• MacOS, Windows and web browser access
• Support for remote workers and sharing reports with different clinical systems
Learn more about Augnito
See how Augnito Spectra is already delivering transformational benefits – and measurable value – for medical professionals across the UK. Request a demo to try Augnito Spectra for 7 days and see the benefits for yourself.